Kaarin J Anstey Selected Research

Mediterranean Diet

1/2022	Nutrition Module design in Maintain Your Brain: an internet-based randomised controlled trial to prevent cognitive decline and dementia.
11/2020	Lifestyle Risk Factors and Cognitive Outcomes from the Multidomain Dementia Risk Reduction Randomized Controlled Trial, Body Brain Life for Cognitive Decline (BBL-CD).
1/2019	MIND not Mediterranean diet related to 12-year incidence of cognitive impairment in an Australian longitudinal cohort study.
1/2018	Body, Brain, Life for Cognitive Decline (BBL-CD): protocol for a multidomain dementia risk reduction randomized controlled trial for subjective cognitive decline and mild cognitive impairment.
7/2012	The Mediterranean diet is not related to cognitive change in a large prospective investigation: the PATH Through Life study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kaarin J Anstey Research Topics

Disease

36	Cognitive Dysfunction 01/2023 - 05/2005
30	Dementia (Dementias) 10/2023 - 05/2008
15	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2007
14	Hypertension (High Blood Pressure) 01/2023 - 04/2005
8	Stroke (Strokes) 01/2023 - 04/2005
8	Atrophy 01/2018 - 01/2007
6	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2015
3	Obesity 01/2022 - 01/2020
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022 - 08/2013
2	Inflammation (Inflammations) 05/2022 - 01/2021
2	Atrial Fibrillation 01/2022 - 01/2019
2	Anxiety Disorders (Anxiety Disorder) 01/2022 - 02/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2007
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2019 - 01/2017
2	Genetic Risk Score 01/2019 - 12/2015
2	Cerebral Cortical Thinning 05/2017 - 11/2016
2	Neoplasms (Cancer) 01/2016 - 06/2015
1	Chronic Disease (Chronic Diseases) 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Hyperhomocysteinemia 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Noncommunicable Diseases 01/2021
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Albuminuria 01/2019
1	Arthritis (Polyarthritis) 01/2019
1	Major Depressive Disorder (Major Depressive Disorders) 02/2018
1	Dizziness (Lightheadedness) 01/2018
1	Orthostatic Hypotension (Postural Hypotension) 01/2018
1	Breast Neoplasms (Breast Cancer) 06/2015
1	Insulin Resistance 01/2015
1	Ischemic Stroke 01/2014
1	Tobacco Use Disorder (Nicotine Dependence) 07/2012
1	Olfaction Disorders (Cacosmia) 05/2012
1	Cataract (Cataracts) 01/2011
1	Heart Diseases (Heart Disease) 06/2007
1	Craniocerebral Trauma (Head Injury) 04/2005

Drug/Important Bio-Agent (IBA)

17	Apolipoproteins E (ApoE)IBA 01/2023 - 01/2007
14	ApolipoproteinsIBA 11/2020 - 01/2007
10	CholesterolIBA 01/2022 - 05/2008
7	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2007
5	Biomarkers (Surrogate Marker)IBA 05/2022 - 12/2007
4	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 01/2016
4	Blood Glucose (Blood Sugar)IBA 01/2018 - 01/2013
2	PesticidesIBA 01/2022 - 08/2013
2	insulin receptor-related receptor (IRR)IBA 02/2018 - 06/2016
2	antineoplaston A10 (A 10)IBA 01/2018 - 05/2017
1	Retinaldehyde (Retinal)IBA 10/2023
1	Amyloid (Amyloid Fibrils)IBA 05/2022
1	Particulate MatterIBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	LDL CholesterolIBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	DiureticsIBA 01/2020
1	AlbuminsIBA 01/2019
1	Air Pollutants (Pollutants, Air)IBA 01/2019
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2019
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2018
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2018
1	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2018
1	hydroxide ionIBA 01/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	ClusterinIBA 10/2017
1	HDL CholesterolIBA 01/2017
1	Triglycerides (Triacylglycerol)IBA 01/2017
1	Vehicle Emissions (Emissions, Vehicle)IBA 05/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2016
1	Insulin (Novolin)FDA Link 01/2016
1	C-Reactive ProteinIBA 01/2015
1	Capsules (Microcapsules)IBA 01/2015
1	MineralsIBA 01/2014
1	PotassiumIBA 01/2014
1	CalciumIBA 01/2014
1	MagnesiumIBA 01/2014
1	Hypnotics and Sedatives (Sedatives)IBA 09/2012
1	Nicotine FDA Link 07/2012
1	FatsIBA 07/2012
1	Cholinergic Antagonists (Anticholinergics)IBA 06/2009
1	Antidepressive Agents (Antidepressants)IBA 06/2007
1	BuffersIBA 01/2007
1	Indicators and Reagents (Reagents)IBA 05/2005
1	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2005
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 04/2005

Therapy/Procedure

5	Mediterranean Diet 01/2022 - 07/2012
5	Activities of Daily Living (ADL) 01/2021 - 01/2012
2	Cognitive Training 10/2023 - 01/2017
1	Resistance Training 01/2022
1	Dietary Approaches To Stop Hypertension 01/2019
1	CD protocol 01/2018
1	Respite Care 01/2018
1	Therapeutics 01/2018
1	Secondary Prevention 01/2018
1	Occupational Therapy (Therapy, Occupational) 02/2017
1	Drug Therapy (Chemotherapy) 06/2015
1	Eye Protective Devices (Goggles) 01/2011
1	Self Administration (Administration, Self) 06/2008